vs

Side-by-side financial comparison of BELLRING BRANDS, INC. (BRBR) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $537.3M, roughly 1.3× BELLRING BRANDS, INC.). Healthpeak Properties runs the higher net margin — 73.2% vs 8.1%, a 65.0% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs 0.8%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $-7.3M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 4.2%).

Bellring Brands, Inc. develops, manufactures and sells high-quality protein and functional nutritional products including ready-to-drink shakes, protein bars, powders and snacks. Its core brands Premier Protein, Dymatize and PowerBar serve health-conscious consumers and fitness enthusiasts across North America via retail, e-commerce and specialty channels.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

BRBR vs DOC — Head-to-Head

Bigger by revenue
DOC
DOC
1.3× larger
DOC
$719.4M
$537.3M
BRBR
Growing faster (revenue YoY)
DOC
DOC
+2.2% gap
DOC
3.1%
0.8%
BRBR
Higher net margin
DOC
DOC
65.0% more per $
DOC
73.2%
8.1%
BRBR
More free cash flow
DOC
DOC
$364.3M more FCF
DOC
$357.0M
$-7.3M
BRBR
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
4.2%
BRBR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BRBR
BRBR
DOC
DOC
Revenue
$537.3M
$719.4M
Net Profit
$43.7M
$114.0M
Gross Margin
29.9%
Operating Margin
14.6%
17.4%
Net Margin
8.1%
73.2%
Revenue YoY
0.8%
3.1%
Net Profit YoY
-43.2%
2406.4%
EPS (diluted)
$0.36
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRBR
BRBR
DOC
DOC
Q4 25
$537.3M
$719.4M
Q3 25
$648.2M
$705.9M
Q2 25
$547.5M
$694.3M
Q1 25
$588.0M
$702.9M
Q4 24
$532.9M
$698.0M
Q3 24
$555.8M
$700.4M
Q2 24
$515.4M
$695.5M
Q1 24
$494.6M
$606.6M
Net Profit
BRBR
BRBR
DOC
DOC
Q4 25
$43.7M
$114.0M
Q3 25
$59.6M
$-117.1M
Q2 25
$21.0M
$31.7M
Q1 25
$58.7M
$42.8M
Q4 24
$76.9M
$4.5M
Q3 24
$71.7M
$85.9M
Q2 24
$73.7M
$146.0M
Q1 24
$57.2M
$6.7M
Gross Margin
BRBR
BRBR
DOC
DOC
Q4 25
29.9%
Q3 25
28.9%
58.6%
Q2 25
35.4%
60.2%
Q1 25
32.3%
61.1%
Q4 24
37.5%
60.3%
Q3 24
36.9%
60.0%
Q2 24
36.8%
60.6%
Q1 24
33.2%
59.8%
Operating Margin
BRBR
BRBR
DOC
DOC
Q4 25
14.6%
17.4%
Q3 25
15.8%
9.2%
Q2 25
8.2%
5.7%
Q1 25
16.2%
7.7%
Q4 24
21.6%
-2.2%
Q3 24
20.2%
14.1%
Q2 24
21.7%
22.3%
Q1 24
18.4%
3.7%
Net Margin
BRBR
BRBR
DOC
DOC
Q4 25
8.1%
73.2%
Q3 25
9.2%
-16.6%
Q2 25
3.8%
4.6%
Q1 25
10.0%
6.1%
Q4 24
14.4%
0.7%
Q3 24
12.9%
12.3%
Q2 24
14.3%
21.0%
Q1 24
11.6%
1.1%
EPS (diluted)
BRBR
BRBR
DOC
DOC
Q4 25
$0.36
$0.16
Q3 25
$0.48
$-0.17
Q2 25
$0.16
$0.05
Q1 25
$0.45
$0.06
Q4 24
$0.59
$0.02
Q3 24
$0.54
$0.12
Q2 24
$0.56
$0.21
Q1 24
$0.43
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRBR
BRBR
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$64.1M
$467.5M
Total DebtLower is stronger
$1.2B
$9.8B
Stockholders' EquityBook value
$-510.7M
$7.5B
Total Assets
$1.1B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRBR
BRBR
DOC
DOC
Q4 25
$64.1M
$467.5M
Q3 25
$71.8M
$91.0M
Q2 25
$43.7M
$89.4M
Q1 25
$28.1M
$70.6M
Q4 24
$49.6M
$119.8M
Q3 24
$70.8M
$180.4M
Q2 24
$72.6M
$106.9M
Q1 24
$79.3M
$101.8M
Total Debt
BRBR
BRBR
DOC
DOC
Q4 25
$1.2B
$9.8B
Q3 25
$1.1B
$9.1B
Q2 25
$1.0B
$9.0B
Q1 25
$953.7M
$8.9B
Q4 24
$833.4M
$8.7B
Q3 24
$833.1M
$8.6B
Q2 24
$832.7M
$8.6B
Q1 24
$832.4M
$8.8B
Stockholders' Equity
BRBR
BRBR
DOC
DOC
Q4 25
$-510.7M
$7.5B
Q3 25
$-453.9M
$7.6B
Q2 25
$-309.9M
$7.9B
Q1 25
$-254.1M
$8.2B
Q4 24
$-146.6M
$8.4B
Q3 24
$-205.9M
$8.6B
Q2 24
$-243.2M
$8.8B
Q1 24
$-247.7M
$8.9B
Total Assets
BRBR
BRBR
DOC
DOC
Q4 25
$1.1B
$20.3B
Q3 25
$941.0M
$19.6B
Q2 25
$993.7M
$19.8B
Q1 25
$947.5M
$19.8B
Q4 24
$885.2M
$19.9B
Q3 24
$837.0M
$20.0B
Q2 24
$804.1M
$20.2B
Q1 24
$765.0M
$20.5B
Debt / Equity
BRBR
BRBR
DOC
DOC
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRBR
BRBR
DOC
DOC
Operating Cash FlowLast quarter
$-3.1M
$1.3B
Free Cash FlowOCF − Capex
$-7.3M
$357.0M
FCF MarginFCF / Revenue
-1.4%
49.6%
Capex IntensityCapex / Revenue
0.8%
124.4%
Cash ConversionOCF / Net Profit
-0.07×
10.99×
TTM Free Cash FlowTrailing 4 quarters
$246.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRBR
BRBR
DOC
DOC
Q4 25
$-3.1M
$1.3B
Q3 25
$169.1M
$315.0M
Q2 25
$40.3M
$363.5M
Q1 25
$48.2M
$279.4M
Q4 24
$3.0M
$1.1B
Q3 24
$40.1M
$318.2M
Q2 24
$69.0M
$316.2M
Q1 24
$16.3M
$152.6M
Free Cash Flow
BRBR
BRBR
DOC
DOC
Q4 25
$-7.3M
$357.0M
Q3 25
$168.1M
Q2 25
$38.5M
Q1 25
$47.6M
Q4 24
$1.7M
$333.7M
Q3 24
$38.9M
Q2 24
$68.9M
Q1 24
$16.0M
FCF Margin
BRBR
BRBR
DOC
DOC
Q4 25
-1.4%
49.6%
Q3 25
25.9%
Q2 25
7.0%
Q1 25
8.1%
Q4 24
0.3%
47.8%
Q3 24
7.0%
Q2 24
13.4%
Q1 24
3.2%
Capex Intensity
BRBR
BRBR
DOC
DOC
Q4 25
0.8%
124.4%
Q3 25
0.2%
Q2 25
0.3%
Q1 25
0.1%
Q4 24
0.2%
105.6%
Q3 24
0.2%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
BRBR
BRBR
DOC
DOC
Q4 25
-0.07×
10.99×
Q3 25
2.84×
Q2 25
1.92×
11.48×
Q1 25
0.82×
6.52×
Q4 24
0.04×
235.43×
Q3 24
0.56×
3.71×
Q2 24
0.94×
2.17×
Q1 24
0.28×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRBR
BRBR

Shakesandotherbeverages$432.4M80%
Powders$92.1M17%
Other Products$12.8M2%

DOC
DOC

Segment breakdown not available.

Related Comparisons